Data Privacy and AI-Driven Pharmaceutical Surveillance: A Legal Perspective

Abstract

Important elements of drug security and oversight include legal structures for monitoring and disclosing negative drug reactions and after-market surveillance of pharmaceutical goods. ADRs must be tracked and reported to regulatory authorities under these frameworks, which include laws, rules, and policies. This research provides some materials and methods which help to gather information related to this topic. Once they’ve been placed on the market, they also set up processes for ongoing drug surveillance in order to guarantee the continuous safety and effectiveness of pharmaceuticals. The result of this study gathers the information and discussion helps to identify the area of the study which is essential. Through the identification and mitigation of possible dangers related to pharmaceutical goods, the facilitation of prompt interventions, and the promotion of openness and responsibility in the pharmaceutical business, these legal frameworks seek to safeguard public health

Keywords

Pharmacovigilance, Adverse drug reactions, Pharmaceutical sector, Medications, Monitoring